For instance, while most studies indicate a high demand for Arg in tumor cells, and ASS1—the rate-limiting enzyme for Arg synthesis—is frequently overexpressed in CRC, biliary and pancreatic malignant tumors often rely more heavily on exogenous Arg uptake165. Here, ASS1 is linked to neoplasm.